DEBUG: PAGE=domain, TITLE=Search all Content,ID=505,TEMPLATE=search
toggle expanded view

Search all content here

from:
until:

Subscribe to blogs & alerts:

manage email alerts using the form below, in order to be notified via email whenever we publish new content:

Access our analyst expertise:

Only NelsonHall clients who are logged in have access to our analysts and advisors for their expert advice and opinion.

To find out more about how NelsonHall's analysts and sourcing advisors can assist you with your strategy and engagements, please contact our sales department here.

Conduent - Pharmaceuticals / Life Sciences Operational Transformation

Vendor Analysis

by Alisa Samoylova

published on Oct 05, 2021

Access to this report is restricted to logged in clients with access. Login to get full access

Report Overview:

This NelsonHall vendor assessment analyzes Conduent's offerings and capabilities in Pharmaceuticals / Life Sciences Operational Transformation

Who is this Report for:

NelsonHall’s pharmaceuticals / life sciences operational transformation profile on Conduent is a comprehensive assessment of Conduent’s offerings and capabilities, designed for:

  • Sourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals / life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs
  • Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
  • Financial analysts and investors specializing in the pharmaceuticals / life sciences services sector.

Scope of this Report:

The report provides a comprehensive and objective analysis of Conduent’s pharmaceuticals / life sciences operational transformation offerings and capabilities, and market and financial strengths, including:

  • Identification of the company’s strategy, emphasis, and new developments
  • Analysis of the company’s strengths, weaknesses, and outlook
  • Revenue estimates
  • Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts
  • Analysis of the company’s offerings and key service components
  • Analysis of the company’s delivery organization, including the location of delivery locations. 

Key Findings & Highlights:

Conduent, which was spun off from Xerox Business Services in 2017, has solutions targeting payer, provider, pharma & life sciences, and government health services. Within its pharma and life sciences business, Conduent currently offers:

  • Patient access solutions
  • Patient and provider engagement solutions
  • Medical information and clinical trial support.

In 2020, Conduent began to re-invest in the pharma & life sciences business. As a result of these investments, Conduent grew the pharmaceutical and life sciences pipeline seven times vs. 2019.

Login to get full access:

close